BL 301 Pill - blue capsule/oblong
Generic Name: hyoscyamine/methenamine/methylene blue/phenyl salicylate/sodium biphosphate
Pill with imprint BL 301 is Blue, Capsule/Oblong and has been identified as Azuphen MB hyoscyamine sulfate 0.12 mg / methenamine 120 mg / methylene blue 10 mg / phenyl salicylate 36 mg / sodium phosphate monobasic 40.8 mg. It is supplied by Burel Pharmaceuticals, Inc.
Azuphen MB is used in the treatment of Urinary Tract Infection and belongs to the drug class urinary antispasmodics. Risk cannot be ruled out during pregnancy. Azuphen MB hyoscyamine sulfate 0.12 mg / methenamine 120 mg / methylene blue 10 mg / phenyl salicylate 36 mg / sodium phosphate monobasic 40.8 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for BL 301
Azuphen MB
- Generic Name
- hyoscyamine/methenamine/methylene blue/phenyl salicylate/sodium biphosphate
- Imprint
- BL 301
- Strength
- hyoscyamine sulfate 0.12 mg / methenamine 120 mg / methylene blue 10 mg / phenyl salicylate 36 mg / sodium phosphate monobasic 40.8 mg
- Color
- Blue
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Urinary antispasmodics
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Burel Pharmaceuticals, Inc.
- National Drug Code (NDC)
- 35573-0314 (Discontinued)
- Inactive Ingredients
-
calcium phosphate dibasic anhydrous,
microcrystalline cellulose,
sodium starch glycolate type A corn,
magnesium stearate,
carbomer 934
Note: Inactive ingredients may vary.
Related images for "BL 301"
More about Azuphen MB (hyoscyamine / methenamine / methylene blue / phenyl salicylate / sodium biphosphate)
- Check interactions
- Compare alternatives
- Imprints, shape & color data
- Side effects
- Drug class: urinary antispasmodics
Patient resources
Other brands
Uribel, Uro-MP, Phosphasal, Urimar-T, ... +15 more
Professional resources
Other brands
Uribel, Phosphasal, Urimar-T, Urelle, ... +8 more
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.